Nicox and Immco to develop Sjögren's syndrome diagnostic device

Article

Nicox has joined forces with Immco Diagnostics to offer tests for the early detection of Sjögren's syndrome.

Nicox has joined forces with Immco Diagnostics to offer tests for the early detection of Sjögren's syndrome.

The collaboration aims to give eye care practitioners and patients increased access to the test that offers potentially more efficient management of the chronic disease.

Undiagnosed Sjögren's syndrome could be discovered in as many as 1 in 10 dry eye patients and could lead to other disorders of the exocrine glands and an increased risk of lymphoma.

The new test, developed by researchers at the University at Buffalo, New York, USA, combines novel and traditional markers that support an accurate and early diagnosis with high sensitivity and specificity.

Nicox Inc Executive Vice President and General Manager, Mr Jerry St Peter, commented, “Immco is a well-established and innovative organization with a reputation for cutting edge science and high quality products. The addition of this new test into our portfolio synergizes well with our existing point-of-care offering, and will contribute to the momentum we are building in the marketplace with AdenoPlus.”

Related Videos
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
 Allen Ho, MD, presented a paper on the 12 month results of a mutation agnostic optogenetic programme for patients with severe vision loss from retinitis pigmentosa
Noel Brennan, MScOptom, PhD, a clinical research fellow at Johnson and Johnson
ARVO 2024: President-elect SriniVas Sadda, MD, speaks with David Hutton of Ophthalmology Times
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Paul Kayne, PhD, on assessing melanocortin receptors in the ocular space
Osamah Saeedi, MD, MS, at ARVO 2024
© 2024 MJH Life Sciences

All rights reserved.